Fusion Antibodies Ltd (FAB) ORD GBP0.04
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
6.10p
6.46p
10.50p
£6.40 million
6.10p
5.83p
2.90p
n/a
0.00p (0.00%) Previous:
0.00p
88,529
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/03/2024 | 31/03/2023 |
|---|---|---|
| Revenue (£m) | 1.14 | 2.90 |
| Profit before tax (£m) | (2.29) | (2.86) |
| Adjusted EPS (p): | (3.90) | (10.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Fusion Antibodies validation project with US NIC progresses
31 January 2025 10:09
-
Fusion Antibodies reports positive recent trading
8 October 2024 15:40
-
Fusion Antibodies strengthens financial position despite revenue decline
5 September 2024 13:53
-
Investor presentation
8 May 2025 07:00
-
Issue of shares to non-executive directors
7 May 2025 07:00
-
Director/PDMR Shareholding
6 May 2025 10:53
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.